-+ 0.00%
-+ 0.00%
-+ 0.00%

Medifast Sees Q4 GAAP EPS $0.00-$0.25 vs $(0.12) Est; Sees Sales $55.000M-$75.000M vs $64.100M Est

Benzinga·10/26/2026 12:08:24
Diffusion vocale
Medifast (NYSE:MED) is looking for Q4 GAAP EPS of $0.00-$0.25 vs $(0.12) analyst estimate. sees sales of $55.000 million-$75.000 million vs $64.100 million analyst estimate.